HLA-A11 Publications

HLA-A11 Model Page

Filter publications by application: All Dengue HIV Hepatitis-B Immuno-Oncology Infectious Disease Oncology Vaccine Research
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Wang QJ, et al.
Mouse over for full list
Wang QJ, Yu Z, Griffith K, Hanada K, Restifo NP, Yang JC
(2016) Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors. Cancer Immunol Res 4(3):204-14
Oncology, Immuno-Oncology
El Bissati K, et al.
Mouse over for full list
El Bissati K, Chentoufi AA, Krishack PA, Zhou Y, Woods S, Dubey JP, Vang L, Lykins J, Broderick KE, Mui E, Suzuki Y, Sa Q, Bi S, Cardona N, Verma SK, Frazeck L, Reardon CA, Sidney J, Alexander J, Sette A, Vedvick T, Fox C, Guderian JA, Reed S, Roberts CW, McLeod R
(2016) Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii. JCI Insight 1(15):e85955
Infectious Disease, Vaccine Research
Kotturi MF, et al.
Mouse over for full list
Kotturi MF, Botten J, Sidney J, Bui HH, Giancola L, Maybeno M, Babin J, Oseroff C, Pasquetto V, Greenbaum JA, Peters B, Ting J, Do D, Vang L, Alexander J, Grey H, Buchmeier MJ, Sette A
(2009) A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease. PLoS Pathog. 5(12):e1000695
Infectious Disease, Vaccine Research
Pasquetto V, et al.
Mouse over for full list
Pasquetto V, Bui HH, Giannino R, Banh C, Mirza F, Sidney J, Oseroff C, Tscharke DC, Irvine K, Bennink JR, Peters B, Southwood S, Cerundolo V, Grey H, Yewdell JW, Sette A
(2005) HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol. 175(8):5504-15
Infectious Disease
El Bissati K, et al.
Mouse over for full list
El Bissati K, Zhou Y, Paulillo SM, Raman SK, Karch CP, Roberts CW, Lanar DE, Reed S, Fox C, Carter D, Alexander J, Sette A, Sidney J, Lorenzi H, Begeman IJ, Burkhard P, McLeod R
(2017) Protein nanovaccine confers robust immunity against Toxoplasma. NPJ Vaccines 2:24
Vaccine Research
Weiskopf D, et al.
Mouse over for full list
Weiskopf D, Yauch LE, Angelo MA, John DV, Greenbaum JA, Sidney J, Kolla RV, De Silva AD, de Silva AM, Grey H, Peters B, Shresta S, Sette A
(2011) Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J. Immunol. 187(8):4268-79
Infectious Disease, Dengue, Vaccine Research
Wilson CC, et al.
Mouse over for full list
Wilson CC, McKinney D, Anders M, MaWhinney S, Forster J, Crimi C, Southwood S, Sette A, Chesnut R, Newman MJ, Livingston BD
(2003) Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1. J. Immunol. 171(10):5611-23
Infectious Disease, HIV, Vaccine Research
McKinney DM, et al.
Mouse over for full list
McKinney DM, Skvoretz R, Livingston BD, Wilson CC, Anders M, Chesnut RW, Sette A, Essex M, Novitsky V, Newman MJ
(2004) Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL. J. Immunol. 173(3):1941-50
HIV, Vaccine Research
Ishioka GY, et al.
Mouse over for full list
Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A
(1999) Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol. 162(7):3915-25
Vaccine Research
Dubey JP, et al.
Mouse over for full list
Dubey JP, Ferreira LR, Martins J, McLeod R
(2012) Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality. Parasitology 139(1):1-13
Infectious Disease
Depla E, et al.
Mouse over for full list
Depla E, Van der Aa A, Livingston BD, Crimi C, Allosery K, De Brabandere V, Krakover J, Murthy S, Huang M, Power S, Babé L, Dahlberg C, McKinney D, Sette A, Southwood S, Philip R, Newman MJ, Meheus L
(2008) Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections. J. Virol. 82(1):435-50
Hepatitis-B, Vaccine Research
Cong H, et al.
Mouse over for full list
Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, McLeod R
(2010) Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccin... Immunome Res 6:12
Vaccine Research
Alexander J, et al.
Mouse over for full list
Alexander J, Oseroff C, Dahlberg C, Qin M, Ishioka G, Beebe M, Fikes J, Newman M, Chesnut RW, Morton PA, Fok K, Appella E, Sette A
(2002) A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery. J. Immunol. 168(12):6189-98
Vaccine Research
Alexander J, et al.
Mouse over for full list
Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A
(1997) Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J. Immunol. 159(10):4753-61